Should You Buy Moderna Right Now?
Has (NASDAQ: MRNA) finally bottomed out? You may be asking that yourself right now, as shares in the biotech company have held steady at around $25 per share over the past six months.
Moderna might be a shell of its former self, no longer making billions from its COVID-19 vaccine, but it's still sitting on billions of dollars in capital. The company also has many promising candidates in its drug development pipeline.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€26.46
-3.250%
Based on 8 Buy predictions and 10 Sell predictions the sentiment towards Moderna Inc. is rather balanced.
With a target price of 22 € there is a slightly negative potential of -16.86% for Moderna Inc. compared to the current price of 26.46 €.
